Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Interest Coverage Ratio: 2020-2023

  • Relay Therapeutics' Interest Coverage Ratio fell 1029.19% to -33,725.67 in Q1 2023 from the same period last year, while for Mar 2023 it was -9,127.86, marking a year-over-year increase of 7.54%. This contributed to the annual value of -91,174.50 for FY2021, which is 2514.51% down from last year.
  • As of Q1 2023, Relay Therapeutics' Interest Coverage Ratio stood at -33,725.67, which was down 1,029.19% from -2,986.71 recorded in Q1 2022.
  • Over the past 5 years, Relay Therapeutics' Interest Coverage Ratio peaked at 4,373.50 during Q4 2020, and registered a low of -33,725.67 during Q1 2023.
  • Its 3-year average for Interest Coverage Ratio is -15,064.46, with a median of -8,481.00 in 2021.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first surged by 64.78% in 2022, then slumped by 1,029.19% in 2023.
  • Over the past 4 years, Relay Therapeutics' Interest Coverage Ratio (Quarterly) stood at 4,373.50 in 2020, then reached -8,481.00 in 2021, then soared by 64.78% to -2,986.71 in 2022, then slumped by 1,029.19% to -33,725.67 in 2023.
  • Its Interest Coverage Ratio was -33,725.67 in Q1 2023, compared to -2,986.71 in Q1 2022 and -8,481.00 in Q1 2021.